SCOLLO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 2.555
NA - Nord America 2.538
AS - Asia 1.434
SA - Sud America 365
AF - Africa 38
OC - Oceania 3
Totale 6.933
Nazione #
US - Stati Uniti d'America 2.481
IE - Irlanda 1.757
HK - Hong Kong 606
SG - Singapore 596
BR - Brasile 337
IT - Italia 250
GB - Regno Unito 189
DE - Germania 122
FI - Finlandia 67
TR - Turchia 57
FR - Francia 52
IN - India 27
BD - Bangladesh 25
CA - Canada 25
CN - Cina 23
CZ - Repubblica Ceca 22
CH - Svizzera 21
MX - Messico 18
ZA - Sudafrica 18
AT - Austria 15
JP - Giappone 14
KR - Corea 12
PL - Polonia 12
VN - Vietnam 10
AR - Argentina 8
PK - Pakistan 8
RU - Federazione Russa 8
SE - Svezia 8
IQ - Iraq 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AG - Antigua e Barbuda 6
KE - Kenya 6
RO - Romania 6
UZ - Uzbekistan 6
EC - Ecuador 5
EG - Egitto 5
MA - Marocco 5
SA - Arabia Saudita 5
UA - Ucraina 5
IL - Israele 4
JO - Giordania 4
LA - Repubblica Popolare Democratica del Laos 4
PE - Perù 4
ES - Italia 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
LB - Libano 3
LT - Lituania 3
NL - Olanda 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
CO - Colombia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
TH - Thailandia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LY - Libia 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.933
Città #
Dublin 1.743
Dallas 1.351
Hong Kong 605
Boardman 352
Singapore 229
Santa Clara 166
London 150
The Dalles 131
Milan 115
Los Angeles 68
Helsinki 65
Istanbul 46
Seattle 33
Ashburn 31
Munich 30
Catania 28
São Paulo 28
Assago 22
Zurich 21
Frankfurt am Main 20
Brno 18
Düsseldorf 16
Brooklyn 14
Council Bluffs 14
Palermo 14
Rome 13
Johannesburg 11
San Francisco 11
Seoul 10
Tokyo 10
Warsaw 10
Belo Horizonte 9
Mexico City 9
Rio de Janeiro 9
Campinas 8
Dhaka 8
West Jordan 8
Brasília 7
Chennai 7
Misterbianco 7
New York 7
Stockholm 7
Manchester 6
Portsmouth 6
St John's 6
Tashkent 6
Vienna 6
Atlanta 5
Curitiba 5
Falkenstein 5
Goiânia 5
Montreal 5
Nairobi 5
Phoenix 5
Roubaix 5
Amman 4
Ankara 4
Beijing 4
Boston 4
Chicago 4
Columbus 4
New Delhi 4
Nuremberg 4
Ottawa 4
Pianopoli 4
San Jose 4
Sorocaba 4
Vientiane 4
Vila Velha 4
Washington 4
Bexley 3
Buffalo 3
Cabo Frio 3
Charlotte 3
Denver 3
Fortaleza 3
Guayaquil 3
Hanoi 3
Islamabad 3
Juazeiro do Norte 3
Maracaibo 3
Moscow 3
Nova Iguaçu 3
Olomouc 3
Osasco 3
Piscataway 3
Porto Alegre 3
Ribeirão das Neves 3
Rio Branco 3
Riyadh 3
Salvador 3
Santo André 3
Sessa Aurunca 3
Shanghai 3
Wickford 3
Alfenas 2
Almaty 2
Aparecida de Goiânia 2
Aracaju 2
Baghdad 2
Totale 5.676
Nome #
Exploit the γ-Glutamyl hydroxymethyl rhodamine green fluorescence in surgical resection: A systematic literature review on clinical indications, fields of application and outcomes 106
Uterosacral Ligament Suspension Sec Shull by Vaginal Natural Transluminal Endoscopic Surgery (vNOTES) 82
Feasibility and safety of robotic single-port surgical staging in epithelial ovarian cancer using the da Vinci SP platform: a preliminary experience 77
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 76
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 76
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 76
Endometrial carcinosarcoma without myoinvasion 75
1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer 70
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab 70
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 67
[Peritonectomy and hyperthermic chemoperfusion in peritoneal carcinomatosis. Preliminary results] 66
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study 66
Psychological and personality assessment in patients candidates for Uterus Transplantation from deceased donor: preliminary results 64
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 64
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 62
A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer 61
Down-regulation of long non-coding RNAs in reproductive aging and analysis of the lncRNA-miRNA-mRNA networks in human cumulus cells 59
#534 Prognosis of surgically staged FIGO IA uterine carcinosarcoma without myometrial invasion: a multicenter international retrospective cohort study 59
The apoptotic transcriptome of the human MII oocyte: characterization and age-related changes 58
Adnexal Torsion in Pediatric Age: Does Bolli's Score Work? Report of Two Cases. 58
Strategies for preventing group B streptococcal infections in newborns: A nation-wide survey of Italian policies 57
A very rare case of uterine PEComa HMB45 negative: primitive or relapse? 57
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial 57
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 56
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 55
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 55
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 55
Azoospermic patient's treatment: An experience of a PMA hospital unit and role of ultrasonography 55
Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies 54
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 54
T cells in ovarian cancer. 54
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 54
Management of cervical pregnancy: a diagnostic and therapeutic approach 53
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study. 53
Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis 53
Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain 52
Utilizzo del "Ligasure" nella isterectomia addominale: rapporto costi-benefici 52
The way a nose could affect pregnancy: severe and recurrent epistaxis. 52
Deceased Donor Uterus Transplantation: A Narrative Review of the First 24 Published Cases 52
Anomalie di sede della gravidanza: la gravidanza ectopica e "unknown location" 52
Sacral agenesis: Case report [Agenesia del sacro: Case report] 52
Italian Journal Of Obstestrics & Gynaecology on web: A one-year balance 51
Adhesions and pain in women with first diagnosis of endometriosis: Results from a cross-sectional study 51
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial 51
TAF4B is a molecular marker of oocyte quality 51
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group. 50
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 50
Frequenza e determinanti di complicanze tromboemboliche venose nelle pazienti sottoposte ad intervento chirurgico per una patologia neoplastica di interesse ginecologico 49
Recurrence of aggressive angiomyxoma of the vulva: a case report 49
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary? 49
Alcohol and pregnancy: What actually the women should know 49
Diagnosi ecografica delle malformazioni fetali. Malformazioni urinarie: possibilita' e limiti diagnostici 48
Miomectomia laparoscopica intracapsulare versus non intracapsulare: studio prospettico con l'ecografia transvaginale 48
Monitoring of the lower urinary tract function after radical Wertheim-Meigs hysterectomy 48
Polyglandular Autoimmune Syndrome in pregnancy: case report 48
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation 48
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation 48
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 47
Serotonin and dopamine play complementary roles in gambling to recover losses. 47
Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery: An Italian initial experience 47
Patologia benigna dell'utero 47
Molecular profiling of follicular fluid miRNAs in young women affected by Hodgkin Lymphoma 47
Percutaneous-assisted laparoscopic bilateral salpingo-oophorectomy in BRCA-mutated patients: a retrospective comparative study 46
Laparoscopic surgery for isolated inguinal node relapse of high grade serous ovarian cancer using a bipolar combination instrument 46
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 46
Dilatation and Curettage after Uterine Artery Embolization versus Methotrexate Injection for the Treatment of Cesarean Scar Pregnancy: A Single-Center Experience 46
Benign Multicystic Omental Mesothelioma in Pregnancy: A Case Report and Review of the Literature 46
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study. 45
Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluid 45
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 45
Urinary, Gastrointestinal, and Sexual Dysfunctions after Chemotherapy, Radiotherapy, Radical Surgery or Multimodal Treatment in Women with Locally Advanced Cervical Cancer: A Multicenter Retrospective Study 44
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 44
Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA trial 44
High prevalence of thyroid dysfunction in pregnant women 43
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 43
Effects of Deep Versus Moderate Neuromuscular Blockade in Laparoscopic Gynecologic Surgery on Postoperative Pain and Surgical Conditions: Protocol for a Randomized Controlled Trial.Effects of Deep Versus Moderate Neuromuscular Blockade in Laparoscopic Gynecologic Surgery on Postoperative Pain and Surgical Conditions: Protocol for a Randomized Controlled Trial 43
Early solitary splenic metastasis of endometrial cancer: a case report and review of literature 43
Colorectal endometriosis: aggressive surgical management and practical considerations in a patient with advanced disease. 42
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 42
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial 42
Diminished ovarian reserve and ectopic ovaries in patients with Mayer-Rokitansky-Küster-Hauser syndrome candidates for Uterus Transplantation: our experience 42
Obstructive Sleep Apnea in Pregnancy: A Comprehensive Review of Maternal and Fetal Implications 41
MicroRNAs upregulated in follicular fluid are carried by exosomes: new actors in the communication between oocyte and somatic follicular cells? 41
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 41
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OvAR-2.2 trial 40
Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation 40
Genetic screening in young women diagnosed with endometrial cancer 40
MicroRNAs are stored in the human MII oocyte and their expression profile changes in reproductive aging 40
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 39
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group 39
Ovarian aging increases small extracellular vesicle CD81+ release in human follicular fluid and influences miRNA profiles 39
Cumulative Sum Analysis of Learning Curve Process for Vaginal Natural Orifice Transluminal Endoscopic Surgery Hysterectomy 39
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 38
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 38
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 38
A Circular RNA Derived from the Pumilio 1 Gene Could Regulate PTEN in Human Cumulus Cells 38
TAp73 is downregulated in oocytes from women of advanced reproductive age 38
CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. 38
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial 37
Indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with vulvar cancer: peritumoral injection dosage and waiting times in our experience 37
Totale 5.127
Categoria #
all - tutte 42.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202343 0 0 0 0 0 0 0 0 0 0 20 23
2023/20242.534 10 28 203 136 371 246 461 228 179 194 278 200
2024/20252.817 210 106 220 66 288 142 207 125 402 546 349 156
2025/20261.763 388 1.342 33 0 0 0 0 0 0 0 0 0
Totale 7.157